Cagle and Bermicker: A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care

A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care

Philip T. Cagle, MD; Eric H. Bernicker, MD

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.